We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Following two other firms, Pfizer filed its own petitions with the PTO over a Herceptin patent owned by Genentech, as it continues to develop its biosimilar. Read More
The Department of Justice announced plans to review the Drug Enforcement Administration’s efforts to combat the spread of illegal opioid use through the agency’s enforcement actions against industry companies. Read More
The Supreme Court’s ruling this week on a patent dispute over printer toner cartridges could have wider effects on the pharmaceutical industry, international sales and product reimportation. Read More
Amgen is suing the FDA, requesting that its Sensipar medication be granted six additional months of pediatric market exclusivity after it completed three of four pediatric clinical trials requested by the agency. Read More
Merck and Optum, a division of UnitedHealth Group, have launched a multi-year collaboration exploring value-based payment models for pharmaceuticals. Read More
With federal action on drug prices and cost transparency stalled in Congress, three states have pushed through their own legislation, with one bill becoming law and another awaiting a governor’s signature. Read More